Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_assertion type Assertion NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_head.
- NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_assertion description "[Reduced expression of both synaptopodin and GLEPP1 is associated with poor response to steroid therapy in primary focal segmental glomerulosclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_provenance.
- NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_assertion evidence source_evidence_literature NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_provenance.
- NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_assertion SIO_000772 16564554 NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_provenance.
- NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_assertion wasDerivedFrom lhgdn-20090331 NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_provenance.
- NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_assertion wasGeneratedBy ECO_0000203 NP216276.RA1bc3_oBROnzvvoz1MOBQYX3FR1p5Cdc2Wf8Ws3yQ-LE130_provenance.